Yıl: 2009 Cilt: 55 Sayı: 1 Sayfa Aralığı: 30 - 35 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Meme kanseri ile ilişkili lenfödem ve konservatif tedavisi

Öz:
Lenfödem lenfatik dolaşımın konjenital veya edinsel bazı nedenlerle bozulması sonucu, proteinden zengin interstisiyel sıvının jeneralize veya bölgesel olarak birikimiyle karakterize bir durumdur. Üst ve alt ekstremitede sekonder lenfödemin en sık nedeni kanserle ilişkili lenfödemdir. Meme kanseri nedeniyle tedavi gören hastaların önemli bir kısmında sekonder üst ekstremite lenfödemi gelişmekte ve hastalarda fonksiyonel kısıtlılığa yol açmaktadır. Meme kanseri ile ilişkili lenfödem insidansı %2,4 ile 56 arasında rapor edilmiştir. Cerrahi olarak uygulanan geniş aksiller lenf nodu diseksiyonu ve radyasyon, lenfödem gelişimi için en önemli risk faktörleridir. Tedavi ile ilişkili komplikasyonları ve lenfödem gelişimini önleyici yaklaşımların yanı sıra, bu sakatlayıcı durumun tedavisinde çeşitli girişimler önerilmiştir. Ancak iyi tasarlanmış yeterli randomize çalışma olmadığından lenfödemin uygun tedavisi ile ilgili bir görüş birliği bulunmamaktadır. Kompleks dekonjestif tedavi, manuel lenfatik drenaj, basit lenfatik drenaj, pnömotik pompalar, laser tedavisi, oral ilaçlar, kompresyon bandajı ve giysileri, ekstremite egzersizleri ve elevasyonu lenfödem tedavisinde sık kullanılan konservatif girişimler arasındadır.Bu derlemede lenfödem gelişimi için risk faktörleri, değerlendirme yöntemleri, önleyici yaklaşımlar ve tedavi girişimleri gözden geçirilmiştir.
Anahtar Kelime: Tanı Meme neoplazmları Risk faktörleri Lenf ödem Tedavi

Konular: Rehabilitasyon

Breast cancer related lymphedema and conservative therapies

Öz:
Lymphedema is characterized by generalized or regional accumulation of protein-rich interstitial fluid that occurs as a consequence of congenital or acquired disruption of lymphatic circulation. Cancer-related lymphedema is the most common cause of secondary upper and lower extremity lymphedema.Secondary arm lymphedema is a chronic and disabling condition which affects a significant number of women who undergo breast cancer treatment. The incidence of breast cancer-related lymphedema was reported to be between 2.4 to 56%. Extensive surgical nodal clearing and irradiation are the most important risk factors for the development of lymphedema. Besides preventive approaches of treatment related complications and lymphedema, various therapeutic interventions have been proposed to treat this disabling condition. In the absence of well-designed randomized studies, consensus has not been attained concerning the appropriate treatment of lymphedema. Complex decongestive therapy, manual lymphatic drainage, self-adminitered lymphatic drainage, pneumatic pumps, laser therapy, oral pharmaceuticals, compression bandaging and garments, limb exercises and elevation are among the common conservative therapies used for managing lymphedema.This review overviews the risk factors, assessment methods, preventive approaches and treatment regimens that have been used for the management of lymphedema.
Anahtar Kelime: Lymphedema Therapy Diagnosis Breast Neoplasms Risk Factors

Konular: Rehabilitasyon
Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • 1. Badger C, Preston N, Seers K, Mortimer P. Physical therapies for reducing and controlling lymphoedema of the limbs. Cochrane Database Syst Rev 2004;18:CD003141.
  • 2. Szuba A, Achalu R, Rockson SG. Decongestive lymphatic therapy for patients with breast carcinoma associated lymphedema. Cancer 2002;95:2260-7.
  • 3. Petrek JA, Heelan MC. Incidence of breast carcinoma-related lymphedema. Cancer 1998;83:2776-81.
  • 4. Badger C, Preston N, Seers K, Mortimer P. Benzo-pyrones for reducing and controlling lymphoedema of the limbs. Cochrane Database Syst Rev 2004;2:CD003140.
  • 5. Cheville AL. Current and future trends in lymphedema management: implications for women’s health. Phys Med Rehabil Clin N Am 2007;18:539-53.
  • 6. Erickson VS, Pearson ML, Ganz PA, Adams J, Kahn KL. Arm edema in breast cancer patients. J Natl Cancer Inst 2001;93:96-111.
  • 7. Wilke LG, McCall LM, Posther KE, Whitworth PW, Reintgen DS, Leitch AM, et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 2006;13:491-500.
  • 8. Ozaslan C, Kuru B. Lymphedema after treatment of breast cancer. Am J Surg 2004;187:69-72.
  • 9. Hinrichs CS, Watroba NL, Rezaishiraz H, Giese W, Hurd T, Fassl KA, et al. Lymphedema secondary to postmastectomy radiation: incidence and risk factors. Ann Surg Oncol 2004;11:573-80.
  • 10. Silver JK. Rehabilitation in women with breast cancer. Phys Med Rehabil Clin N Am 2007;18:521-37.
  • 11. Canavese G, Catturich A, Vecchio C, Tomei D, Gipponi M, Bruzzi P, et al. Prognostic role of lymph-node level involvement in patients undergoing axillary dissection for breast cancer. Eur J Surg Oncol 1998;24:104-9.
  • 12. Rietman JS, Geertzen JH, Hoekstra HJ, Baas P, Dolsma WW, de Vries J, et al. Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer. Eur J Surg Oncol 2006;32:148-52.
  • 13. McKenzie DC, Kalda AL. Effect of upper extremity exercise on secondary lymphedema in breast cancer patients: a pilot study. J Clin Oncol 2003;21:463-6.
  • 14. Ahmed RL, Thomas W, Yee D, Schmitz KH. Randomized controlled trial of weight training and lymphedema in breast cancer survivors. J Clin Oncol 2006;24:2765-72.
  • 15. Rockson SG, Miller LT, Senie R, Brennan MJ, Casley-Smith JR, Foldi E, et al. American Cancer Society Lymphedema Workshop. Workgroup III: Diagnosis and management of lymphedema. Cancer 1998;83:2882-5.
  • 16. Gerber LH. A review of measures of lymphedema. Cancer 1998;83:2803-4.
  • 17. Mayrovitz HN, Sims N, Macdonald J. Assessment of limb volume by manual and automated methods in patients with limb edema or lymphedema. Adv Skin Wound Care 2000;14:272-6.
  • 18. Carati CJ, Anderson SN, Gannon BJ, Piller NB. Treatment of postmastectomy lymphedema with low-level laser therapy. Cancer 2003;98:1114-22.
  • 19. Harris SR, Hugi MR, Olivotto IA, Levine M. Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema. CMAJ 2001;164:191-9.
  • 20. Piller NB, Thelander A. Treatment of chronic postmastectomy lymphedema with low level laser therapy: A 2.5 year follow-up. Lymphology 1998;31:74-86.
  • 21. Dini D, Del Mastro L, Gozza A, Lionetto R, Garrone O, Forno G et al. The role of pneumatic compression in the treatment of postmastectomy lymphedema. A randomized phase III study. Ann Oncol 1998;9:187-90.
  • 22. Ko SC, Lerner R, Klose G, Cosimi B. Effective treatment of lymphedema of the extremities. Arch Surg 1998;133:452-8.
  • 23. Mortimer PS. Managing lymphoedema. Clin Exp Dermatol 1995;20:98-106.
  • 24. Moseley AL, Carati CJ, Piller NB. A systematic review of common conservative therapies for arm lymphoedema secondary to breast cancer treatment. Ann Oncol 2007;18:639-46.
  • 25. Bernas MJ, Witte CL, Witte MH; International Society of Lymphology Executive Committee. The diagnosis and treatment of peripheral lymphedema: draft revision of the 1995 Consensus Document of the International Society of Lymphology Executive Committee for discussion at the September 3-7, 2001, XVIII International Congress of Lymphology in Genoa, Italy. Lymphology. 2001;34:84-91.
  • 26. Brennan MJ, Miller LT. Overview of treatment options and review of the current role and use of compression garments, intermittent pumps, and exercise in the management of lymphedema. Cancer 1998;83:2821-7.
  • 27. Johansson K, Lie E, Ekdahl C, Lindfeldt J. A randomized study comparing manual lymph drainage with sequential pneumatic compression for treatment of postoperative arm lymphedema. Lymphology 1998;31:56-64.
  • 28. Kaviani A, Fateh M, Nooraie RY, Alinagi-zadeh MR, Ataie-Fashtami L. Low-level laser therapy in management of postmastectomy lymphedema. Lasers Med Sci 2006;21:90-4.
  • 29. Swedborg I, Norrefalk JR, Piller NB, Asard C. Lymphoedema post-mastectomy: is elevation alone an effective treatment? Scand J Rehabil Med 1993;25:79-82.
  • 30. Markes M, Brockow T, Resch KL. Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Database Syst Rev 2006;18:CD005001.
  • 31. Andersen L, Hojris I, Erlandsen M, Andersen J. Treatment of breast-cancer-related lymphedema with or without manual lymphatic drainage-a randomized study. Acta Oncologica 2000;39:399-405.
  • 32. Badger CM, Peacock JL, Mortimer PS. A randomized, controlled, parallel-group clinical trial comparing multilayer bandaging followed by hosiery versus hosiery alone in the treatment of patients with lymphedema of the limb. Cancer 2000;88:2832-7.
  • 33. Hornsby R. The use of compression to treat lymphoedema. Professional Nurse 1995;11:127-8.
APA Basaran S, KOZANOĞLU M (2009). Meme kanseri ile ilişkili lenfödem ve konservatif tedavisi. , 30 - 35.
Chicago Basaran Sibel,KOZANOĞLU MUSTAFA ERKAN Meme kanseri ile ilişkili lenfödem ve konservatif tedavisi. (2009): 30 - 35.
MLA Basaran Sibel,KOZANOĞLU MUSTAFA ERKAN Meme kanseri ile ilişkili lenfödem ve konservatif tedavisi. , 2009, ss.30 - 35.
AMA Basaran S,KOZANOĞLU M Meme kanseri ile ilişkili lenfödem ve konservatif tedavisi. . 2009; 30 - 35.
Vancouver Basaran S,KOZANOĞLU M Meme kanseri ile ilişkili lenfödem ve konservatif tedavisi. . 2009; 30 - 35.
IEEE Basaran S,KOZANOĞLU M "Meme kanseri ile ilişkili lenfödem ve konservatif tedavisi." , ss.30 - 35, 2009.
ISNAD Basaran, Sibel - KOZANOĞLU, MUSTAFA ERKAN. "Meme kanseri ile ilişkili lenfödem ve konservatif tedavisi". (2009), 30-35.
APA Basaran S, KOZANOĞLU M (2009). Meme kanseri ile ilişkili lenfödem ve konservatif tedavisi. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, 55(1), 30 - 35.
Chicago Basaran Sibel,KOZANOĞLU MUSTAFA ERKAN Meme kanseri ile ilişkili lenfödem ve konservatif tedavisi. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi 55, no.1 (2009): 30 - 35.
MLA Basaran Sibel,KOZANOĞLU MUSTAFA ERKAN Meme kanseri ile ilişkili lenfödem ve konservatif tedavisi. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, vol.55, no.1, 2009, ss.30 - 35.
AMA Basaran S,KOZANOĞLU M Meme kanseri ile ilişkili lenfödem ve konservatif tedavisi. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi. 2009; 55(1): 30 - 35.
Vancouver Basaran S,KOZANOĞLU M Meme kanseri ile ilişkili lenfödem ve konservatif tedavisi. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi. 2009; 55(1): 30 - 35.
IEEE Basaran S,KOZANOĞLU M "Meme kanseri ile ilişkili lenfödem ve konservatif tedavisi." Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, 55, ss.30 - 35, 2009.
ISNAD Basaran, Sibel - KOZANOĞLU, MUSTAFA ERKAN. "Meme kanseri ile ilişkili lenfödem ve konservatif tedavisi". Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi 55/1 (2009), 30-35.